Biological Products Regulation: A Practical Guide to BLA, MAA, and CMC Requirements for Biologics
The regulatory pathway for biological products is fundamentally different from that for small molecule drugs — and significantly more complex. Biologics, including monoclonal antibodies, therapeutic proteins, vaccines, and gene therapies, are derived from living systems and are inherently more variable,